Based on the evidence that GHRH antagonists were able to suppress experimental tumor growth and that a subset of endometrial carcinoma expressed receptors for GHRH, the application of powerful new GHRH antagonists could be useful for the treatment of this type of malignancy [36]. This evidence concerns the gene GHRH and endometrial carcinoma.